Feasibility assessment of in vitro chemoresponse assay on stereotactic biopsies of glioblastoma multiforms: a step towards personalized medicine

Objective(s):P In vitro chemosensitivity and resistance assays (CSRAs) are a promising tool for personalized treatment of glioblastoma multiform (GBM). These assays require a minimum of 1 to 2 g of tumor specimen for testing, but this amount is not always accessible. We aimed to assess the feasibili...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fariba Sadeghi Fazel, Mahnaz Haddadi, Alireza Khoshnevisan, Samad Muhammadnejad, Ahad Muhammadnejad, Zohreh Mazaheri, Motahareh Arjomandnejad, Reza Shirkoohi, Mohammad-Ali Oghabian, Narjes Sherkat-Khameneh, Saeid Amanpour, Monireh Kazemimanesh
Formato: Artigo
Lenguaje:Inglês
Publicado: Mashhad University of Medical Sciences 2014-11-01
Colección:Iranian Journal of Basic Medical Sciences
Materias:
Glioblastomamultiform In vitro chemosensitivity and resistance assay Personalized medicine Primary explant technique Stereotactic biopsy
Acceso en línea:http://ijbms.mums.ac.ir/pdf_3747_18889a2b2c356f4ab92fad027b03e2be.html
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares